Effect of Metformin on Antipsychotic-Induced Metabolic Dysfunction: The Potential Role of Gut-Brain Axis
Antipsychotics are the first-line medications prescribed for patients with schizophrenia or other mental disorders. Cumulative evidence has revealed that metabolic dysfunctions frequently occur in patients receiving antipsychotics, especially second-generation antipsychotics, and these effects may d...
Main Authors: | Chao Luo, Xu Wang, Hanxue Huang, Xiaoyuan Mao, Honghao Zhou, Zhaoqian Liu |
---|---|
Format: | Article |
Language: | English |
Published: |
Frontiers Media S.A.
2019-04-01
|
Series: | Frontiers in Pharmacology |
Subjects: | |
Online Access: | https://www.frontiersin.org/article/10.3389/fphar.2019.00371/full |
Similar Items
-
The Gut Microbiome in Schizophrenia and the Potential Benefits of Prebiotic and Probiotic Treatment
by: Jonathan C. W. Liu, et al.
Published: (2021-03-01) -
Recognizing Depression from the Microbiota–Gut–Brain Axis
by: Shan Liang, et al.
Published: (2018-05-01) -
Outcomes and safety of concomitant topiramate or metformin for antipsychotics-induced obesity: a randomized-controlled trial
by: Congjie Wang, et al.
Published: (2020-12-01) -
Gut Microbiota-brain Axis
by: Hong-Xing Wang, et al.
Published: (2016-01-01) -
Metformin Enhances Antidepressant/Antipsychotic Combination Therapy of Schizophrenia With Comorbid Depression in a Murine Model
by: Chunhua Zhou, et al.
Published: (2020-06-01)